Evidence check: Skincare DNA in the context of allergy

The evidence for DNA-based skincare recommendations in the context of allergy is weak. Most consumer tests claiming to predict glycation risk, collagen breakdown, or skin sensitivity rely on mechanistic or small observational studies—not robust clinical data. For allergies (e.g., histamine intolerance, pollen allergy), some genetic associations exist, but effect sizes are small and predictive power for individuals is insufficient. The MyBody-X tests for skin glycation and collagen were rated as 'marketing' in the provided context. The link between skin DNA markers and allergic reactions is not supported by strong human studies. Consumers should be aware that such tests do not replace medical diagnosis and often create false expectations. A dermatological or allergological workup with established methods (prick test, specific IgE, skin analysis) is more meaningful.